ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31

Actinium Pharmaceuticals, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$1.32+0.19 (+16.81%)

Close on Oct 19, 2026

Market cap: $41.46M
P/E (TTM): 3.7
Dividend yield: –

Actinium Pharmaceuticals, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Cash & Equivalents	36	42	48	53	60	66	73	79	86	84	77	83	92	95	110	113	117	72	78	82	82	73	64	49	54	6.38	9.69	15	20	10	14	15	22	27	18	21	12	17	21	16
Cash & Short-Term Investments	36	42	48	53	60	66	73	79	86	84	77	83	92	95	110	113	117	72	78	82	82	73	64	49	54	6.38	9.69	15	20	10	14	15	22	27	18	21	12	17	21	16
Prepaid Expenses & Other	1.27	1.13	1.38	0.98	1.10	1.13	1.60	0.86	1.03	1.32	1.59	2.62	4.26	3.63	1.64	1.21	1.53	1.59	1.48	1.18	1.21	1.45	1.32	0.90	0.99	0.82	0.79	0.19	0.34	0.30	0.62	0.31	0.57	0.84	0.44	0.67	1.01	1.03	1.84	1.56
Other Current Assets	–	–	0.17	–	–	–	0.36	–	–	–	0.23	–	–	–	0.07	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Assets	38	43	49	54	61	66	75	80	87	85	78	86	96	99	111	113	118	74	80	83	83	74	65	49	55	6.81	10	15	20	10	14	15	22	28	18	21	12	18	22	17
Property, Plant & Equipment	0.70	0.27	0.30	0.23	0.27	0.32	0.36	0.41	0.46	0.50	0.55	0.60	0.62	0.63	0.60	0.64	0.56	0.32	0.34	0.37	0.33	0.29	0.31	0.09	0.09	0.10	0.11	0.12	0.13	0.14	0.12	0.10	0.06	0.05	0.06	0.07	0.07	0.08	0.09	0.09
Accumulated Depreciation	-0.85	-1.09	-1.06	-1.03	-0.99	-0.94	-0.89	-0.84	-0.79	-0.76	-0.69	-0.64	-0.59	-0.54	-0.49	-0.44	-0.40	-0.36	-0.34	-0.37	-0.34	-0.31	-0.29	-0.27	-0.26	-0.25	-0.24	-0.23	-0.21	-0.20	-0.27	-0.25	-0.24	-0.23	-0.22	-0.22	-0.21	-0.19	-0.17	-0.15
Operating Lease Right-of-Use Assets	1.37	1.57	1.75	1.22	1.37	1.53	1.69	1.84	1.99	2.14	2.29	2.44	2.58	2.54	2.34	2.45	2.63	0.15	0.24	0.33	0.41	0.50	0.58	0.66	0.74	0.82	0.81	0.96	1.04	1.11	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.20	–	–	0.10	–
Total Assets	40	45	52	56	63	69	77	82	90	88	81	89	99	102	114	117	122	75	80	84	84	75	66	51	56	8.36	12	16	22	12	15	16	23	28	18	22	13	18	23	17
Accounts Payable	8.51	6.62	7.25	6.22	7.71	6.52	7.57	7.20	9.18	–	7.95	–	–	–	–	–	–	–	–	–	–	–	4.34	4.22	4.09	4.04	4.60	5.13	4.70	5.32	5.81	4.12	5.27	6.39	4.65	3.45	3.60	4.77	4.19	2.57
Current Portion of Leases	0.74	0.73	0.71	0.60	0.59	0.58	0.57	0.55	0.54	0.54	0.53	0.52	0.51	0.50	0.49	0.39	0.29	0.15	0.25	0.33	0.36	0.35	0.34	0.34	0.33	0.32	0.29	0.31	0.30	0.29	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	–	–	–	–	0.10	–	–	0.10	0.20	0.10	1.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.09	0.20	0.27	1.00	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	9.26	7.35	7.97	6.83	8.31	7.11	8.15	7.76	9.73	8.06	8.49	8.67	9.15	7.86	11	8.35	6.28	5.72	6.84	4.19	3.87	4.16	4.77	4.68	4.66	4.71	5.34	5.54	5.18	5.85	6.06	4.12	5.27	6.39	4.67	3.53	4.11	5.37	4.52	3.03
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.90	0.10	0.30	0.20	–	–	–	–	–	–	–	–	–	–
Long-Term Leases	0.60	0.79	0.97	0.53	0.69	0.84	0.98	1.14	1.28	1.41	1.55	1.69	–	–	2.08	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.34	1.51	1.68	1.13	1.27	1.42	1.55	1.69	1.82	1.95	2.08	2.08	0.51	0.50	2.58	0.39	0.29	0.15	0.25	0.33	0.36	0.35	0.34	0.34	0.33	0.32	0.29	0.31	0.30	0.29	–	–	–	–	–	–	–	–	–	–
Total Liabilities	9.86	43	44	42	44	43	44	44	46	44	45	45	46	45	48	46	44	5.73	6.84	4.19	3.96	4.36	5.08	5.10	5.18	5.34	6.03	6.38	6.12	6.89	6.08	4.12	5.27	6.39	4.67	3.53	4.11	5.37	4.52	3.03
Total Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.90	0.10	0.30	0.20	–	–	–	–	–	–	–	–	–	–
Preferred Stock	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	0	–
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.18	0.01	0.16	0.16	0.12	0.12	0.11	0.11	0.11	0.08	0.08	0.06	0.06	0.06	0.05
Additional Paid-In Capital	418	418	418	418	418	417	409	407	401	390	374	372	368	357	355	349	347	330	329	328	322	307	292	270	270	217	214	214	213	198	196	192	192	191	177	176	160	157	155	144
Retained Earnings	-387	-415	-410	-404	-399	-392	-376	-369	-358	-346	-338	-328	-315	-300	-289	-278	-269	-261	-256	-248	-241	-236	-231	-225	-219	-214	-209	-204	-198	-193	-187	-181	-174	-169	-163	-158	-152	-145	-137	-130
Comprehensive Income & Other	-0.06	-0.04	-0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	30	2.30	7.83	14	19	26	33	38	44	44	36	44	53	57	66	71	78	69	74	80	80	71	61	45	51	3.02	5.64	9.94	16	5.34	8.81	12	17	22	14	18	8.87	13	18	14
Total Equity	30	2.30	7.83	14	19	26	33	38	44	44	36	44	53	57	66	71	78	69	74	80	80	71	61	45	51	3.02	5.64	9.94	16	5.34	8.81	12	17	22	14	18	8.87	13	18	14
Total Liabilities & Equity	40	45	52	56	63	69	77	82	90	88	81	89	99	102	114	117	122	75	80	84	84	75	66	51	56	8.36	12	16	22	12	15	16	23	28	18	22	13	18	23	17
Shares Outstanding(shares)	31	31	31	31	31	31	31	31	31	29	28	27	27	26	26	25	25	22	22	22	21	19	18	14	13	5.83	5.49	5.49	5.40	3.97	3.86	3.68	3.68	3.68	2.67	2.67	1.95	1.91	1.86	1.59
Deposits	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.39	–	–	–	0.39	0.39	0.39	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: 10617.8%
Net margin: 12564.4%
Return on equity, FY2025: -167.0%

Financial strength

Current ratio: 4.08
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 393.9%

Valuation

P/E ratio: 3.7
Price to sales: 460.63
Price to book: 1.37
Dividend yield: –